Clean Science and Technology Ltd.
NSE: CLEANClean Science and Technology Ltd.: A 30-second snapshot
Clean Science and Technology (CLEAN) is a specialty chemicals company trading at ₹893.10, currently 5.27% below its 200-DMA of ₹941.05 and 43.85% below its 52-week high. The stock has declined 23.27% over the past 12 months against a backdrop of 5-year earnings contraction of 30.1% and revenue contraction of 8.8%, while a near-term 3-month bounce of 11.73% has pushed RSI to 76.58. Q4 FY26 results are due on May 14.
P/E
37.2
Forward P/E
33.0
ROE
—
Debt / Equity
0.14
Profit Margin
+25.3%
Div. Yield
+0.7%
5Y ROE > 15%
4/5
5Y FCF > 0
3/5
Quality
43/100
News
8 headlines · 2 positive · 1 negative
Clean Science and Technology Q4 Results - Mint
Mint
Clean Science to Detail Q4 Results on May 14 Amid Revenue Declines - Whalesbook
Whalesbook
Chemical Stock Where FIIs and DIIs Ignored Its Profit Dip and Increased Their Stake from 4% to 17% - Trade Brains
Trade Brains
Why FIIs doubled down on this specialty chemical leader despite negative PAT growth - financialexpress.com
financialexpress.com
TDB-DST supports NTF Energy Solutions Pvt. Ltd. for Commercialisation of Indigenous Type-IV CNG Cylinders under India's Clean Mobility Vision - PIB
PIB
Recent context
- ·Q4 FY26 results are scheduled for May 14, 2026; headline news noted revenue declines in the run-up, and the Q4 outcome will be the next material data point on whether the multi-year contraction is stabilising.
- ·Multiple recent articles highlighted rising FII and DII stake ownership despite negative PAT growth — institutional positioning is diverging from reported earnings trends, a tension that the Q4 print may resolve in either direction.
- ·The 3-month price gain of 11.73% has coincided with the institutional interest narrative, but the stock remains below its 200-DMA of ₹941.05, and nearest resistance is at ₹913.64 — a level that has not yet been reclaimed.
Strengths
- +Profit margin of 25.28% indicates that despite revenue decline, the business has retained meaningful earnings relative to sales — a structural characteristic of specialty chemical niche operators.
- +Debt-to-equity of 0.142 is low, suggesting the balance sheet carries limited financial leverage risk even as the debt trend is marked as rising.
- +PE of 37.24 is mid-ranked (3rd of 6) within the peer group — below Pidilite (59.7) and Solar Industries (100.9), indicating relative valuation compression versus higher-rated peers.
- +Forward PE of 32.96 represents a modest discount to the trailing PE of 37.24, reflecting some expectation of earnings recovery in the near term.
Weaknesses
- −5-year earnings growth of -30.1% and revenue growth of -8.8% indicate persistent deterioration in the core business over the medium term — not a single-year event.
- −Quality score of 27 ranks 5th out of 6 peers in the Chemicals sector, with FCF positive in only 3 of available years and a rising debt trend.
- −Stock is 43.85% below its 52-week high and has been below the 200-DMA, down 23.27% over 12 months — the extended price drawdown reflects cumulative fundamental underperformance.
- −Earnings consistency score of 52/100 combined with ROE unavailable in the current period suggests recent profitability metrics are incomplete, limiting confidence in the quality picture.
Open questions
- ?Does the 25.28% profit margin reflect a durable moat in specialty chemistry, or is it eroding as the 5-year earnings decline of 30.1% suggests the pricing power is fading?
- ?What is driving the 5-year revenue contraction of 8.8% — loss of key customer contracts, Chinese competition in key product categories, or a volume/price mix shift — and how is management addressing it?
- ?Does the reported rise in FII/DII institutional stake represent conviction in a fundamental turnaround, or is it a mechanical rebalancing into a depressed-price name with no earnings catalyst yet confirmed?
- ?How does the Q4 FY26 result on May 14 compare to analyst expectations embedded in the forward PE of 32.96, and does the trajectory of operating margins confirm or challenge the multi-year contraction narrative?
Peer comparison: Chemicals
Ranks 5 of 6 on quality| Symbol | Name | P/E | ROE | Quality |
|---|---|---|---|---|
| CLEAN | Clean Science and Technology Ltd.You're viewing | 37.2 | — | 27 |
| Industry avg | across 5 peers | 53.3 | +17.6% | 44 |
| PIDILITIND | Pidilite Industries Ltd. | 59.7 | +23.5% | 66 |
| SOLARINDS | Solar Industries India Ltd. | 101.0 | — | 57 |
| SRF | SRF Ltd. | 45.1 | +13.8% | 41 |
| COROMANDEL | Coromandel International Ltd. | 28.1 | +15.6% | 30 |
| PIIND | PI Industries Ltd. | 32.4 | — | 25 |
Technical state
Current price
₹893.10
SMA 50
₹747.88
SMA 200
₹941.05
RSI (14)
76.6 (overbought)
From 52w high
-43.9%
1Y return
-23.3%
3M return
+11.7%
50-DMA
Above
200-DMA
Below
Algorithmic support levels
Algorithmic resistance levels
Risk flags
- high5-year earnings growth of -30.1% and 5-year revenue growth of -8.8% indicate sustained top-line and bottom-line deterioration over the medium term.
- highStock is 43.85% below its 52-week high and 5.27% below the 200-DMA (₹941.05), down 23.27% over 12 months — an extended drawdown without recovery to the long-term average.
- mediumRSI at 76.58 is in overbought territory, while the 3-month price gain of 11.73% has outpaced the 12-month trend — near-term momentum is stretched relative to structural price weakness.
- mediumQuality score of 27 ranks 5th of 6 peers in the Chemicals sector; debt trend is rising and FCF was positive in only 3 of the available years, with earnings consistency score of 52/100.
Cross-section contradictions
- 5-year ROE was above 15% for 4 years and profit margin stands at 25.28%, suggesting historically profitable operations, yet earnings growth is -30.1% over 5 years and revenue growth is -8.8% — profitability is compressing despite a historically strong margin base.
- FII and DII stake has reportedly increased (per news headlines) despite negative PAT growth and a 43.85% drawdown from highs, creating a divergence between institutional accumulation behaviour and deteriorating reported fundamentals.
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.
Fundamentals & technicals: refreshed 25 Jun 2026 · refreshed daily at 01:00 IST
AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 12 May 2026 · rotates through NIFTY 500 every ~5 days